Forecasting the prevalence of overweight and obesity in India to 2040
In India, the expanding predominance of overweight and obesity can be observed in recent years. The relationship between overweight and obesity with many non-communicable...
Author: Megha Desai
NT-pro BNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial
For patients having diabetes with co-occurring cardiovascular and renal complications, circulating NT-pro BNP levels have a similar comparative capacity as multivariate models to forecast...
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
The characteristic of pulmonary arterial hypertension is cellular proliferation, pulmonary vascular remodeling, and poor long-term outcomes. Sotatercept is a novel fusion protein that binds...
Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
Measurement of blood glucose is a well-established factor of concern when treating an individual with diabetes. On the other hand, there is no knowledge...
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2•4 mg for weight management: a randomised, controlled, phase 1b trial
Cagrilintide is a long-acting amylin analogue, and semaglutide 2•4 mg is a glucagon-like peptide-1 analogue. Both the drugs have been investigated as options for...
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo controlled randomised trial.
Diabetes is a major risk factor for erectile dysfunction, however, there is less knowledge on the effect of GLP-1 receptor agonists on erectile dysfunction....
